Status:
COMPLETED
Stereotactic Body Radiation Therapy (SBRT) for Lung Tumors
Lead Sponsor:
University of Florida
Conditions:
Lung Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this research study is to determine if Stereotactic Body Radiation Therapy(SBRT) is a good way to treat tumors near the thorax. Stereotactic Body Radiation Therapy (SBRT) is a general t...
Detailed Description
Stereotactic Body Radiotherapy (SBRT) for tumors in the thorax is a relatively new therapy in the United States, but has been used extensively in Japan for more than 10 years. This protocol seeks to e...
Eligibility Criteria
Inclusion
- Informed consent to participate in this protocol
- Patients of all ages are eligible
- All tumor types are eligible
- Patients with prior thoracic radiotherapy and/or surgery are eligible
- Tumor size ≤ 5 cm
Exclusion
- The subject is eligible for surgical resection or prefers treatment on this protocol to surgical resection.
- Less than 1 year since original radiation to thorax for retreatment patients.
- More than 2 tumors requiring SBRT
- The patient cannot be positioned reproducibly due to pain or other factors
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT00632281
Start Date
January 1 2006
End Date
November 1 2008
Last Update
February 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida Shands Cancer Center
Gainesville, Florida, United States, 32610